• Image 01
  • Image 02
  • Image 03
  • Image 04
  • Image 05
  • Image 06
Need assistance? Contact Us: 1-800-255-5897

Menu

  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Cerevel Therapeutics Hldg Inc (NQ: CERE )

44.96 UNCHANGED
Last Price Updated: 4:15 PM EDT, Jul 31, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 0
Open 44.96
Bid (Size) 44.97 (20)
Ask (Size) 44.98 (146)
Prev. Close 44.96
Today's Range 44.96 - 44.96
52wk Range 23.36 - 44.96
Shares Outstanding 8,830,700
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
CERE Investors Have the Opportunity to Join Investigation of Cerevel Therapeutics Holdings, Inc. with the Schall Law Firm
June 18, 2024
From The Schall Law Firm
Via Business Wire
CEREVEL SHAREHOLDER ALERT: Kaskela Law LLC Announces Investigation into Fairness of Cerevel Therapeutics Holdings, Inc. (NASDAQ: CERE) Buyout and Encourages Investors to Contact the Firm
June 11, 2024
From Kaskela Law LLC
Via Business Wire

Performance

YTD
+6.52%
+6.52%
1 Month
N/A
N/A
3 Month
N/A
N/A
6 Month
+5.74%
+5.74%
1 Year
+70.56%
+70.56%

More News

Read More
Calling All Cerevel Therapeutics Holdings, Inc. (CERE) Investors: Contact Bronstein, Gewirtz & Grossman, LLC To Claim Your Losses
June 05, 2024
From Bronstein, Gewirtz & Grossman, LLC
Via Business Wire
10 Health Care Stocks Whale Activity In Today's Session
June 04, 2024
Via Benzinga
Calling All Cerevel Therapeutics Holdings, Inc. (CERE) Investors: Contact Bronstein, Gewirtz & Grossman, LLC To Claim Your Losses
May 29, 2024
From Bronstein, Gewirtz & Grossman, LLC
Via Business Wire
1 Wall Street Analyst Thinks AbbVie Stock Is Going to $200. Is It a Buy at Around $165?
May 20, 2024
Via The Motley Fool
Topics Intellectual Property
Exposures Intellectual Property
CERE Stock Earnings: Cerevel Therapeutics Hldg Misses EPS for Q2 2024
May 09, 2024
Via InvestorPlace
Soon To Be Acquired Cerevel Therapeutics Reveals High Level Data From Late-Stage Parkinson's Disease Study
April 18, 2024
Via Benzinga
Neumora Stock Hits 2024 Low As Side Effects In Rabbits Torpedo Schizophrenia Drug
April 15, 2024
Via Investor's Business Daily
Tuesday Talk: Big-Tech Under Attack
March 26, 2024
Via Talk Markets
Why Is Ulcerative Colitis-Focused Landos Biopharma Stock Trading Higher On Monday?
March 25, 2024
Via Benzinga
3 Unstoppable Mega-Cap Stocks That Every Investor Should Own in 2024
March 09, 2024
Via InvestorPlace
Is AbbVie Stock a Buy Now?
February 22, 2024
Via The Motley Fool
This Analyst Is Bullish On Biohaven's Approach in Neuro-Psych Space
February 16, 2024
Via Benzinga
UBS Bullish On This Depression Drug Maker, Says Alzheimer's Agitation Data Is Attractive Catalyst
February 06, 2024
Via Benzinga
AbbVie Lifts Long-Term Outlook For New Immunology Drugs, Even As Q4 Revenue and Profit Fall
February 02, 2024
Via Benzinga
AbbVie's Transformational 2023, Analyst Anticipates Growth in 2024 Amid Competitive Pressures
January 29, 2024
Via Benzinga
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: McGrath RentCorp (Nasdaq – MGRC), Science 37 Holdings, Inc. (Nasdaq – SNCE), Eagle Bulk Shipping Inc. (NYSE - EGLE), Cerevel Therapeutics Holdings, Inc. (Nasdaq –
January 29, 2024
From Brodsky & Smith LLC
Via GlobeNewswire
ABBV: This Top Biotech Just Went On A Buying Spree
January 25, 2024
Via Talk Markets
7 Dividend Aristocrats That Will Pay You for Years to Come
January 22, 2024
Via InvestorPlace
CERE Stock Alert: Halper Sadeh LLC Is Investigating Whether the Sale of Cerevel Therapeutics Holdings, Inc. Is Fair to Shareholders
January 08, 2024
From Halper Sadeh LLC
Via Business Wire
5 Biotech Stocks That Should Be On Investors' Radar As JPMorgan Healthcare Conference Gets Underway Monday
January 08, 2024
Via Benzinga
Is AbbVie Stock a Buy Now?
January 07, 2024
Via The Motley Fool
Topics Intellectual Property
Exposures Intellectual Property
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Icosavax, Inc. (Nasdaq - ICVX), Rain Oncology, Inc. (Nasdaq – RAIN), Consolidated Communications Holdings, Inc. (Nasdaq - CNSL), Cerevel Therapeutics Holdings, Inc.
January 04, 2024
From Brodsky & Smith LLC
Via GlobeNewswire
Upward Trajectory For Biotech/Pharma M&A: Sector Trends Towards Pre-Pandemic Levels, Forecasts Positive For 2024
December 29, 2023
Via Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.

Having difficulty making your payments? We're here to help! Call 1-800-255-5897

Copyright © 2019 Franklin Credit Management Corporation
All Rights Reserved
Contact Us | Privacy Policy | Terms of Use | Sitemap